Search

Your search keyword '"Nalini, Mahdi"' showing total 111 results

Search Constraints

Start Over You searched for: Author "Nalini, Mahdi" Remove constraint Author: "Nalini, Mahdi"
111 results on '"Nalini, Mahdi"'

Search Results

3. Volatile organic compounds and mortality from ischemic heart disease: A case-cohort study

6. Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019

7. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019

8. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study

10. Exposure to polycyclic aromatic hydrocarbons, volatile organic compounds, and tobacco-specific nitrosamines and incidence of esophageal cancer.

11. Exposure to polycyclic aromatic hydrocarbons, volatile organic compounds, and tobacco-specific nitrosamines and incidence of esophageal cancer

12. Association Between Incident Type 2 Diabetes and Opium Use: Mediation by Body Mass and Adiposity

16. Determinants of Left Ventricular Systolic Function One Year after Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction in a Middle-Income Country

17. Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality

18. Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality.

19. Spatial environmental factors predict cardiovascular and all-cause mortality: Results of the SPACE study

21. Pictogram Is a Valid Instrument to Classify At-Risk Adult Population Based on Abdominal Obesity: Results from Pars Cohort Study

22. Sex difference in the risk factor distributions and outcomes after coronary artery bypass graft surgery in the young population

24. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019

25. Sex difference in the risk factor distributions and outcomes after coronary artery bypass graft surgery in the young population.

26. Obesity and incident gastrointestinal cancers: overall body size or central obesity measures, which factor matters?

27. Additional file 1 of Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study

28. Corrigendum to: Joint effect of diabetes and opiate use on all-cause and cause-specific mortality: the Golestan cohort study

29. Long-term opiate use and risk of cardiovascular mortality: results from the Golestan Cohort Study

30. Joint effect of diabetes and opiate use on all-cause and cause-specific mortality: the Golestan cohort study

31. Impaired Fasting Glucose alone or in combination with Hypertension, Dyslipidemia, or both AND Major Adverse Cardiovascular Events among patients without previous cardiovascular disease.

32. Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial

33. Impact of Pre-diabetes alone or in combination with Hypertension, Dyslipidemia, or both on Major Adverse Cardiovascular Events

34. Effectiveness of Polypill for Primary and Secondary Prevention of Cardiovascular Diseases: A Pragmatic Cluster Randomized Controlled Trial

35. Joint effect of diabetes and opiate use on all-cause and cause-specific mortality: the Golestan cohort study.

36. Long-termopiate use and risk of cardiovascular mortality: results fromthe Golestan Cohort Study.

37. Causes of premature death and their associated risk factors in the Golestan Cohort Study, Iran

38. Long-term opiate use and risk of cardiovascular mortality: results from the Golestan Cohort Study

39. Comparing Anthropometric Indicators of Visceral and General Adiposity as Determinants of Overall and Cardiovascular Mortality.

40. Drug Use for Secondary Prevention of Cardiovascular Diseases in Golestan, Iran: Results From the Golestan Cohort Study.

43. The Effects of Enhanced External Counter Pulsation on Heart Function in Patients with Ischemic Heart Disease and Left Ventricular Dysfunction.

44. Corrigendum to: Joint effect of diabetes and opiate use on all-cause and cause-specific mortality: the Golestan cohort study.

45. Abstract 13476: Spatial Risk Factors Impact Cardiovascular Mortality: Analysis From the Golestan Cohort Study

46. Determinants of Left Ventricular Systolic Function One Year after Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction in a Middle-Income Country.

47. Comparing Anthropometric Indicators of Visceral and General Adiposity as Determinants of Overall and Cardiovascular Mortality

48. Causes of premature death and their associated risk factors in the Golestan Cohort Study, Iran

49. Exposure to polycyclic aromatic hydrocarbons, volatile organic compounds, and tobacco-specific nitrosamines and incidence of esophageal cancer.

50. Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality.

Catalog

Books, media, physical & digital resources